Colombo C - Search Results

1

Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.

Colombo C, Setchell KD, Podda M, Crosignani A, Roda A, Curcio L, Ronchi M, Giunta A. Colombo C, et al. J Pediatr. 1990 Sep;117(3):482-9. doi: 10.1016/s0022-3476(05)81103-5. J Pediatr. 1990. PMID: 2391610

2

Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study.

Colombo C, Crosignani A, Assaisso M, Battezzati PM, Podda M, Giunta A, Zimmer-Nechemias L, Setchell KD. Colombo C, et al. Hepatology. 1992 Oct;16(4):924-30. doi: 10.1002/hep.1840160412. Hepatology. 1992. PMID: 1398498 Clinical Trial.

3

Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease.

Colombo C, Castellani MR, Balistreri WF, Seregni E, Assaisso ML, Giunta A. Colombo C, et al. Hepatology. 1992 Apr;15(4):677-84. doi: 10.1002/hep.1840150421. Hepatology. 1992. PMID: 1551646

4

Effects of taurine and ursodeoxycholic acid on liver function tests in patients with cystic fibrosis.

Colombo C, Battezzati PM, Crosignani A, Assaisso M, Ronchi M, Giunta A. Colombo C, et al. Acta Univ Carol Med (Praha). 1990;36(1-4):148-51. Acta Univ Carol Med (Praha). 1990. PMID: 2130679

5

Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.

Nakagawa M, Colombo C, Setchell KD. Nakagawa M, et al. Among authors: colombo c. Hepatology. 1990 Aug;12(2):322-34. doi: 10.1002/hep.1840120221. Hepatology. 1990. PMID: 2391071

6

Effect of taurine supplementation on fat and bile acid absorption in patients with cystic fibrosis.

Colombo C, Arlati S, Curcio L, Maiavacca R, Garatti M, Ronchi M, Corbetta C, Giunta A. Colombo C, et al. Scand J Gastroenterol Suppl. 1988;143:151-6. doi: 10.3109/00365528809090237. Scand J Gastroenterol Suppl. 1988. PMID: 3164502

7

The steatocrit: a simple method for monitoring fat malabsorption in patients with cystic fibrosis.

Colombo C, Maiavacca R, Ronchi M, Consalvo E, Amoretti M, Giunta A. Colombo C, et al. J Pediatr Gastroenterol Nutr. 1987 Nov-Dec;6(6):926-30. J Pediatr Gastroenterol Nutr. 1987. PMID: 3681578

8

Hepatobiliary disease in cystic fibrosis.

Colombo C, Battezzati PM, Podda M. Colombo C, et al. Semin Liver Dis. 1994 Aug;14(3):259-69. doi: 10.1055/s-2007-1007316. Semin Liver Dis. 1994. PMID: 7939786 Review. No abstract available.

9

Analysis of risk factors for the development of liver disease associated with cystic fibrosis.

Colombo C, Apostolo MG, Ferrari M, Seia M, Genoni S, Giunta A, Sereni LP. Colombo C, et al. J Pediatr. 1994 Mar;124(3):393-9. doi: 10.1016/s0022-3476(94)70361-2. J Pediatr. 1994. PMID: 8120708

10

Oral bile acids in cystic fibrosis-associated liver disease.

Colombo C, Crosignani A, Apostolo MG, Marzano MT, Bettinardi N, Giunta A. Colombo C, et al. J R Soc Med. 1994;87 Suppl 21(Suppl 21):20-4. J R Soc Med. 1994. PMID: 8201582 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,166 results

Search Page